Pancreatic Cancer Research

ResearcherTongji UniversityActive in the last 2 years

Bingdi Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2086-0898; OpenAlex author ID A5004462981. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
10
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 4

  1. Corrigendum to "SiRNA-circFARSA-loaded porous silicon nanomaterials for pancreatic cancer treatment via inhibition of CircFARSA expression" [Biomed. Pharmacoth… Last author DOI 10.1016/j.biopha.2026.119363↗
  2. SiRNA-circFARSA-loaded porous silicon nanomaterials for pancreatic cancer treatment via inhibition of CircFARSA expression. Last author DOI 10.1016/j.biopha.2022.112672↗
  3. Glypican-1-antibody-conjugated Gd-Au nanoclusters for FI/MRI dual-modal targeted detection of pancreatic cancer. Last author DOI 10.2147/ijn.s158559↗
  4. In vitro and in vivo targeting imaging of pancreatic cancer using a Fe3O4@SiO2 nanoprobe modified with anti-mesothelin antibody. Co-author DOI 10.2147/ijn.s104501↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Huixiao Yuan · 2 shared papers, 2022–2026 · strength 0.41
  2. Xin Huang · 2 shared papers, 2018–2022 · strength 0.21
  3. Hua Jiang · 1 shared paper, 2022 · strength 0.14
  4. Shuxian Zhang · 1 shared paper, 2022 · strength 0.14
  5. Chengwei Shao · 2 shared papers, 2016–2018 · strength 0.13
  6. Zheng Cui · 2 shared papers, 2016–2018 · strength 0.13
  7. Wei Li · 1 shared paper, 2018 · strength 0.07
  8. Donglu Shi · 1 shared paper, 2018 · strength 0.07
  9. Fang Liu · 1 shared paper, 2016 · strength 0.06
  10. Luguang Chen · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.